Room Louis Armand 9:00-10:15 AM
ARDS 2019: WHAT’S NEW?
Moderator : D. BRODIE, New York - USA - A. COMBES, Paris - FRA
The French consensus on the management of ARDS D. ROUX, Paris - FRA
Respiratory drive in severe ARDS D. GEORGOPOULOS, Heraklion - GRE
Future targets in severe ARDS: mechanical power, driving pressure, plateau pressure, transpulmonary pressure? A. SLUTSKY, Toronto - CAN
An update on the very latest ARDS trial results N. FERGUSON, Toronto - CAN
Room Louis Armand 10:45-11:45 AM
CARDIOGENIC SHOCK 2019 UPDATE
Moderator : N. BRECHOT, C. SPAULDING, Paris - FRA
Should we revise the definition of cardiogenic shock? C. DELMAS, Toulouse - FRA
A rationale for the use of Levosimendan in cardiogenic shock? B. LEVY, Nancy - FRA
IABP to the Museum C. SPAULDING, Paris - FRA
IABP is not dead G. LEURENT, Rennes - FRA
Industry Viewpoint AnnaLotta Schiller Vestergren, PhD (Olink)
Room Louis Armand 11:45-12:45
ECOS FOR CARDIAC ARREST
Moderator : I. HASSAN, Doha - QAT - M. PINETON, Paris - FRA
Outcome prediction in refractory cardiac arrest: patients selection for ECPR C. SANDRONI, Rome - ITA
Latest French ECPR series W. BOUGOUIN, Paris - FRA
Blood purification to reverse the post-resuscitation syndrome P. HONORE, Brussels - BEL
Room Louis Armand 13:00-14:00
DESIGNING INNOVATIVE EXTRACORPOREAL LIFE SUPPORT STRATEGIES
GETINGE SymposiumModerator : A. COMBES, Paris - FRA - E. GOLIGHER, Toronto - CAN
VA-ECMO/IABP for AMI cardiogenic shock A. COMBES, Paris - FRA
ECCO2R in ICU patients: what’s next? C. KARAGIANNIDIS, Koeln - GER
After EOLIA, who should be considered for ECMO? D. BRODIE, NewYork - USA
Room Louis Armand 14:15-15:30
ECCO2R
Moderator : C. KARAGIANNIDIS, Koeln - GER - M. SCHMIDT, Paris - FRA
CO2 body store and CO2 dynamics C. KARAGIANNIDIS, Koeln - GER
Low VS. High Flow ECCO2R for ARDS > Pros G. CAPELLIER, Besançon - FRA
Low VS. High Flow ECCO2R for ARDS > Cons D. BRODIE, New York - USA
ECCO2R and anticoagulation: results of the HECTOR study J.-L. DIEHL, Paris - FRA
Room Louis Armand 15:30-16:30
ECOS, TCS AND ECMO BURNING QUESTIONS
Moderator : I. HASSAN, Doha - QAT - L. VERCAEMST, Leuven - BEL
Should we abandon surgical cannulation for VA ECMO? G. LEBRETON, Paris - FRA
Predictors of intracranial hemorrhage in adult patients on Extracorporeal Membrane Oxygenation C.-E. LUYT, Paris - FRA
How to organize simulation programs for ECOS? L. VERCAEMST, Leuven - BEL
Room Louis Armand 17:00-18:00
TCS IN AMI PATIENTS
Moderator : F. BEYGUI, Caen - FRA - J.-P. COLLET, Paris - FRA
TCS in AMI and PCI: how to proceed? A. LAUTEN, Berlin - GER
Does the IMPELLA CP improve the outcome of AMI CS patients? D. WESTERMANN, Hamburg - GER
ECMO alone? plus IABP? or ECMELLA in AMI CS… F. PAPPALARDO, Milan - ITA
Room 202/203 14:15-15:30
Room 202/203 15:30-16:30
PEDIATRIC ECMO
Moderator : P.-L. LEGER, J. STARCK, Paris - FRA
Does ECMO improve survival in pediatric acute respiratory failure? P.-L. LEGER, Paris - FRA
Investigator Viewpoint J. STARCK, Paris - FRA
Pharmacokinetics of drugs in Pediatric ECMO M. OUALHA, Paris - FRA
Investigator Viewpoint Anne Cécile Huby, PhD (Nancy, FR)
Room 303 14:15-15:30
ECMO BASICS
Moderator : C. MOSSADEGH, Paris - FRA
VV ECMO: when and how? C. AGERSTRAND, New York - USA
VA ECMO: when and how? J.-A. FOWLES, Papworth - UK
Room Louis Armand 08:30-09:30
TIMING AND MODALITIES OF RRT DURING AKI
Moderator : A. COMBES, S. GAUDRY, Paris - FRA
Delaying Renal Replacement Therapy in Acute Kidney Injury: can we own (more than) the night? S. BARBAR, Nimes - FRA
From VILI to Artificial Kidney-Induced Kidney Injury: a paradigm shift D. DREYFUSS, Paris - FRA
RRT modalities and renal function recovery S. GAUDRY, Paris - FRA
Room Louis Armand 09:30-10:30
COAGULATION AND ANTICOAGULATION QUESTIONS
Moderator : G. HEKIMIAN, Paris - FRA - B. LEVY, Nancy - FRA
HIT on ECMO: does it exist? B. LEVY, Nancy - FRA
TEG-based anticoagulation management during ECOS M. PANIGADA, Milan - ITA
Ion-Exchange Resin Anticoagulation (i-ERA): a novel extracorporeal technique for regional anticoagulation A. ZANELLA, Milan - ITA
Room Louis Armand 11:00-12:15
VV ECMO
Moderator : A. COMBES, Paris - FRA - E. GOLIGHER, Toronto - CAN
Early ECMO VS. conventional MV and salvage ECMO for severe ARDS after EOLIA > Pros D. BRODIE, New York - USA
Early ECMO VS. conventional MV and salvage ECMO for severe ARDS after EOLIA > Cons C. GUERIN, Lyon - FRA
How much spontaneous ventilation in ARDS patients on ECMO? N. DE PROST, Paris - FRA
Impact of ultraprotective MV on lung inflammation on ECMO S. ROZENCWAJG, Paris - FRA
Room Louis Armand 12:30-13:30
ECMO PLUS CYTOSORB - ENHANCE YOUR THERAPEUTIC OPTIONS
CYTOSORBENTS SymposiumModerator : A. COMBES, G. LEBRETON, Paris - FRA
Technical and safety aspects – Experiences from Ulm K. TRÄGER, Ulm - GER
Why do we combine VA ECMO with CytoSorb? Experiences from Milan F. PAPPALARDO, Milan - ITA
Control of hyperinflammation: chances to improve outcome L.-C. NAPP, Hannover - GER
Room Louis Armand 13:45-14:45
TCS IN AMI PATIENTS
Moderator : N. AISSAOUI, Paris - FRA - E. BONNEFOY, Lyon - FRA
Patients with cardiogenic shock should be taken to the closest cath lab L. BONELLO, Marseille - FRA
Patients with cardiogenic shock should be taken to a tertiary shock center regardless of the distance E. BONNEFOY, Lyon - FRA
LV unloading with the Impella to decrease infarct size: a valid concept? D. WESTERMANN, Hamburg - GER
Why do we need TCS RCTs in cardiogenic shock? M. ORBAN, München - GER
Room Louis Armand 14:45-15:45
LATEST ECOS TRIALS
Moderator : E. GOLIGHER, Toronto - CAN - M. SCHMIDT, Paris - FRA
Results of a multicenter international trial of VA ECMO for refractory septic shock N. BRECHOT, Paris - FRA
Secondary analyses of the EOLIA trial M. SCHMIDT, Paris - FRA
Designing the best ECCO2R trial in ARDS patients E. GOLIGHER, Toronto - CAN
Room Louis Armand 16:15-17:15
AN INTEGRATED PERSPECTIVE ON THE FUTURE OF ECOS
Moderator : A. COMBES, Paris - FRA - J. FRASER, Brisbane - AUS
ECOS devices interplay with Inflammation and Coagulation J. FRASER, Brisbane - AUS
Organ cross-talk on ECOS A. COMBES, Paris - FRA
Regional anticoagulation VS. Coagulation-free devices A. ZANELLA, Milan - ITA
Room 202/203 09:30-10:30
TCS/ECMO EMERGING INDICATIONS
Moderator : G LEBRETON, C.-E. LUYT, Paris - FRA
Cardiogenic shock and valvular disease; TAVI, MitraClip, ECMO and Impella: when should you call the interventional cardiologist? N. KARAM, Paris - FRA
Latest results of VA ECMO as a bridge to heart transplantation G. LEBRETON, Paris - FRA
Percutaneous catheter-directed thrombolysis and other percutaneous devices for severe pulmonary embolism P. CLUZEL, Paris - FRA
Room 202/203 11:00-12:15
TCS FOR RIGHT VENTRICLE FAILURE
Moderator : N. BRECHOT, O. MERCIER, Paris - FRA
Management of acute right heart failure in pulmonary hypertension L. SAVALE, Paris - FRA
Right ventricle reverse remodeling E. FADEL, Le Plessis-Robinson - FRA
Factors affecting failure of RV function recovery with LVAD J. GUIHAIRE, Le Plessis-Robinson - FRA
Room 303 09:30-10:30
ECMO EDUCATION
Moderator : C. AGERSTRAND, New York - USA - C. MOSSADEGH, Paris - FRA
How do I educate my team: Team Trousseau A. AMBLARD, Paris - FRA
How do I educate my team: Team Papworth J.-A. FOWLES, Papworth - UK
How do I educate my team: Team New York C. AGERSTRAND, New York - USA
C. MOSSADEGH, Paris - FRA
James Snider, PhD (Critical Dx)